Your browser doesn't support javascript.
loading
Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients.
Ramachandran, Ravishankar; Bhosale, Vivek; Reddy, Himanshu; Atam, Virendra; Faridi, Mma; Fatima, Jalees; Shukla, Vaibhav; Khan, Zaw A; Khan, Hana; Singh, Vikram; Negi, Mahendra Pal Singh; Srivastava, Mukesh; Srivastava, Ajay Kumar; Tripathi, Chandra Bhushan; Ghosh, Nayan; Majumdar, Nilanjana; Tripathi, Raj Kamal; Rath, Srikanta Kumar; Mishra, Prabhat Ranjan; Sharma, Sharad; Kundu, Tapas K.
Affiliation
  • Ramachandran R; CSIR-Central Drug Research Institute, Lucknow. Electronic address: r_ravishankar@cdri.res.in.
  • Bhosale V; CSIR-Central Drug Research Institute, Lucknow.
  • Reddy H; King George's Medical University, Lucknow.
  • Atam V; King George's Medical University, Lucknow.
  • Faridi M; ERA's Lucknow Medical College and Hospital.
  • Fatima J; ERA's Lucknow Medical College and Hospital.
  • Shukla V; ERA's Lucknow Medical College and Hospital.
  • Khan ZA; ERA's Lucknow Medical College and Hospital.
  • Khan H; ERA's Lucknow Medical College and Hospital.
  • Singh V; Ram Manohar Lohia Institute of Medical Sciences, Lucknow.
  • Negi MPS; CSIR-Central Drug Research Institute, Lucknow.
  • Srivastava M; CSIR-Central Drug Research Institute, Lucknow.
  • Srivastava AK; CSIR-Central Drug Research Institute, Lucknow.
  • Tripathi CB; CSIR-Central Drug Research Institute, Lucknow.
  • Ghosh N; CSIR-Central Drug Research Institute, Lucknow.
  • Majumdar N; CSIR-Central Drug Research Institute, Lucknow.
  • Tripathi RK; CSIR-Central Drug Research Institute, Lucknow.
  • Rath SK; CSIR-Central Drug Research Institute, Lucknow.
  • Mishra PR; CSIR-Central Drug Research Institute, Lucknow.
  • Sharma S; CSIR-Central Drug Research Institute, Lucknow.
  • Kundu TK; CSIR-Central Drug Research Institute, Lucknow. Electronic address: director@cdri.res.in.
Int J Infect Dis ; 115: 62-69, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34801738

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Country of publication: